Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
610 participants
OBSERVATIONAL
2023-07-12
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AMPLATZER™ Amulet™ LAA Occluder Trial
NCT02879448
Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy
NCT04676880
Impact of Steerable Delivery Sheaths on Successful Closure of LA A With AMULET
NCT05464511
Omega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial Fibrillation
NCT03526471
Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast Asia Observational Study
NCT05687591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Left atrial appendage occlusion (LAAO)
Implantation of an Amplatzer Amulet left atrial appendage occluder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 18 years of age
* Willing and capable of providing informed consent and participating in all testing associated with this clinical study
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dhanunjaya Lakkireddy, MD
Role: PRINCIPAL_INVESTIGATOR
Kansas City Cardiac Arrhythmia Research Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arizona Arrhythmia Research
Phoenix, Arizona, United States
Arkansas Heart Hospital
Little Rock, Arkansas, United States
Baptist Medical Center
Jacksonville, Florida, United States
Usman R. Siddiqui, MD
Winter Park, Florida, United States
PERC - O'Fallon
O'Fallon, Illinois, United States
Kansas City Cardiac Arrhythmia Research Foundation
Overland Park, Kansas, United States
Cardiovascular Research Institute of Kansas
Wichita, Kansas, United States
Providence Hospital
Southfield, Michigan, United States
Bryan Heart
Lincoln, Nebraska, United States
CHI Health Creighton University Medical Center-Bergan Mercy
Omaha, Nebraska, United States
New York University Hospital
New York, New York, United States
Pinnacle Health System
Mechanicsburg, Pennsylvania, United States
Trident Medical Center
Charleston, South Carolina, United States
Vanderbilt Heart & Vascular Institute
Nashville, Tennessee, United States
Baylor All Saints Medical Center at Fort Worth
Fort Worth, Texas, United States
Heart Rhythm Associates
Shenandoah, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRD_1056
Identifier Type: OTHER
Identifier Source: secondary_id
ABT-CIP-10467
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.